Global STD (Sexually Transmitted Disease) Diagnosis Industry
The Report gives coverage over Comprehensive research on“Global STD (Sexually Transmitted Disease) Diagnosis Market”. The Global STD (Sexually Transmitted Disease) Diagnosis Market is expected to grow at a compound annual growth rate of 8.7% during the forecast period (2017-2022).
Try Sample of Global STD Diagnosis Market @ https://www.wiseguyreports.com/sample-request/2786795-global-std-diagnosis-market-research-and-forecast-2017-2022
In a lack of treatment or awareness, these diseases can lead to major health problems such as not being able to get pregnant (infertility), permanent brain damage, heart disease, cancer, and sometimes people even die due to the STD without any previous symptoms. STD includes a group of more than 25-30 infectious diseases. These are spread through sexual activities. Common sexual transmitted diseases include human immunodeficiency virus, chlamydia, gonorrhoea, syphilis, herpes simplex virus, human papillomavirus and so on.
STD screening services are now widely covered under healthcare services and are likely to augment the growth of the global STD testing market. Regulatory authorities such as the WHO, have outlined strategies for the prevention and control of STDs.
On the other hand, STD’s not being able to be diagnosed restrains the growth of this market. For instance, Asia Pacific is growing at a rapid growth rate due to the increasing incidence of sexually transmitted infections, increasing labs and testing centers for unreached patients in rural areas, and increasing government awareness for reducing the accidents of vehicles that are creating an opportunity for the growth of the market.
The distribution channels segment consists of hospital pharmacies, retail pharmacies, online pharmacies. The online pharmacies segment accounted for the highest market share of 35.39% in 2018 and is expected to dominate the market during the forecast period.
The global STD market is segmented based on
By disease types.
- herpes simplex virus
- human papillomavirus
- human immunodeficiency virus testing
By location of testing.
- Laboratory testing.
- Point of care (POC) testing.
- North America
- Latin America
- Middle East
- South Africa
- Other African Countries.
By Therapy Type:
- Anti-Bacterial Drugs
- Anti-Viral Drugs
- Anti-Fungal Drugs
By Testing Devices:
- Instruments & Systems
- Immunochromatographic assays
- Flow Cytometers
- Differential Light Scattering machines
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Diagnostic Kits
- Phone Chips (Microfluidics + ICT)
- Portable / Bench Top / Rapid Diagnostic Kits
By Route of Administration:
By Distribution Channels:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
North America contributes to the STD diagnosis market. Favorable government initiatives in the US for STDs diagnostics, favorable healthcare infrastructure, and high awareness levels are certain reasons for achieving great heights in this market. Human papillomavirus infection among the female population in the Asia Pacific is considered as the major reason for the fastest growing STD diagnosis market during the time span. This region is seen as a leading market for STD (Sexually Transmitted Disease) Diagnosis in terms of growth. The increasing awareness of personal care in emerging economies of India and China is anticipated to boost the STD diagnosis market during the forecast period.
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/2786795-global-std-diagnosis-market-research-and-forecast-2017-2022
For more information or any query mail at email@example.com
Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
+1 646 845 9349 / +44 208 133 9349